'Limitless' Season 2 Renewal: Amazon Considering To Pick Up The Series But Drug Theme Remains A Concern?

There is no doubt that "Limitless" is one of the most interesting shows today. Thus, it is not surprising when fans are distraught after learning that CBS canceled "Limitless" Season 2. New reports suggest that there could be new hopes for "Limitless."

When Netflix pick up the first season of "Limitless" it instantly gains more fans. The audience binge watches the series and the support for "Limitless" Season 2 grows. Unfortunately, CBS has decided to cancel the series and Netflix has not picked up "Limitless" Season 2 yet, which only extends the agony of the fans.

Parent Herald previously reported that Bradley Cooper is not giving up on the series. The "Limitless" star is wooing FX and Amazon to continue "Limitless" Season 2, which still opens doors for the show's return.

"Limitless" concentrates on a nootropic drug called NZT048 that helps one utilize his capacity. This plot is what makes "Limitless" unique, interesting and appealing to the audience. However, the same theme is holding back some networks to support the renewal of "Limitless" Season 2.

According to FX, the drug element makes some networks skeptical about "Limitless." If they renew the show, other might think that they are supporting these types of drugs.

The dragging renewal of "Limitless" continues to disappoint fans who are expecting to see more of the show. In fact, some fans went frantic when Netflix turned down "Limitless" Season 2 and threatened the network that they will cancel their subscription.

Overall, "Limitless" has a growing fan base, which only makes the show's renewal very appealing. There is no doubt that "Limitless" Season 2 will have high ratings. Now, the concern is should the drug theme in the show be a concern?

Should Amazon pick up "Limitless" Season 2? Are you still hopeful to see more of the show? Share your thoughts in the comment section below.

© 2024 ParentHerald.com All rights reserved. Do not reproduce without permission.

Join the Discussion
Real Time Analytics